These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 37679890

  • 1. Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts.
    Graziosi M, Singh M, Nayak SM, Yaden DB.
    J Psychoactive Drugs; 2023; 55(5):558-569. PubMed ID: 37679890
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.
    Kuc J, Kettner H, Rosas F, Erritzoe D, Haijen E, Kaelen M, Nutt D, Carhart-Harris RL.
    Psychopharmacology (Berl); 2022 May; 239(5):1425-1440. PubMed ID: 34734314
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
    Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R.
    J Psychopharmacol; 2019 Sep; 33(9):1076-1087. PubMed ID: 31294673
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).
    Dworatzyk K, Jansen T, Schmidt TT.
    PLoS One; 2022 Sep; 17(3):e0264927. PubMed ID: 35294453
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.
    Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR.
    J Psychopharmacol; 2021 Apr; 35(4):437-446. PubMed ID: 33427007
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving.
    Sweat NW, Bates LW, Hendricks PS.
    J Psychoactive Drugs; 2016 Apr; 48(5):344-350. PubMed ID: 27719438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The psychedelic effects of cannabis: A review of the literature.
    Wolinsky D, Barrett FS, Vandrey R.
    J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
    [Abstract] [Full Text] [Related]

  • 17. Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland.
    Kangaslampi S, Hausen A, Rauteenmaa T.
    J Psychoactive Drugs; 2020 Jan; 52(4):309-318. PubMed ID: 32511073
    [Abstract] [Full Text] [Related]

  • 18. Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings.
    Pallavicini C, Cavanna F, Zamberlan F, de la Fuente LA, Ilksoy Y, Perl YS, Arias M, Romero C, Carhart-Harris R, Timmermann C, Tagliazucchi E.
    J Psychopharmacol; 2021 Apr; 35(4):406-420. PubMed ID: 33567945
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.